Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer

ClinicalTrials.gov ID: NCT00268463

Public ClinicalTrials.gov record NCT00268463. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Clinical Trial Comparing Oxaliplatin, Capecitabine and Hepatic Arterial Infusion of Floxuridine to Oxaliplatin and Capecitabine in Patients With Resected or Ablated Liver Metastases From Colorectal Cancer

Study identification

NCT ID
NCT00268463
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
NSABP Foundation Inc
Network
Enrollment
22 participants

Conditions and interventions

Interventions

  • capecitabine Drug
  • floxuridine Drug
  • oxaliplatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2005
Primary completion
May 31, 2008
Completion
May 31, 2008
Last update posted
May 14, 2013

2006 – 2008

United States locations

U.S. sites
31
U.S. states
20
U.S. cities
26
Facility City State ZIP Site status
Cancer Care Center at John Muir Health - Concord Campus Concord California 94524-4110
City of Hope Comprehensive Cancer Center Duarte California 91010-3000
Veterans Affairs Medical Center - Loma Linda (Pettis) Loma Linda California 92357
Kaiser Permanente Medical Center - Walnut Creek Walnut Creek California 94596
John Muir/Mt. Diablo Comprehensive Cancer Center Walnut Creek California 94598
CCOP - Christiana Care Health Services Newark Delaware 19713
Washington Cancer Institute at Washington Hospital Center Washington D.C. District of Columbia 20010
Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center Savannah Georgia 31403-3089
Via Christi Cancer Center at Via Christi Regional Medical Center Wichita Kansas 67214
Central Baptist Hospital Lexington Kentucky 40503-9985
Louisville Oncology at Norton Cancer Center Louisville Kentucky 40202
CCOP - Ochsner New Orleans Louisiana 70121
Harry & Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center Baltimore Maryland 21237
Saint Joseph Mercy Cancer Center Ann Arbor Michigan 48106-0995
Borgess Medical Center Kalamazoo Michigan 49001
West Michigan Cancer Center Kalamazoo Michigan 49007-3731
Bronson Methodist Hospital Kalamazoo Michigan 49007
Mayo Clinic Cancer Center Rochester Minnesota 55905
Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina 27157-1096
Altru Cancer Center at Altru Hospital Grand Forks North Dakota 58201
Natalie Warren Bryant Cancer Center at St. Francis Hospital Tulsa Oklahoma 74136
Legacy Good Samaritan Hospital & Medical Center Comprehensive Cancer Center Portland Oregon 97210
CCOP - Columbia River Oncology Program Portland Oregon 97225
Providence St. Vincent Medical Center Portland Oregon 97225
St. Luke's Cancer Network at St. Luke's Hospital Bethlehem Pennsylvania 18015
Geisinger Medical Center Danville Pennsylvania 17822-0001
UMC Southwest Cancer and Research Center Lubbock Texas 79415-3364
Fletcher Allen Health Care - University Health Center Campus Burlington Vermont 05401
Virginia Oncology Associates - Hampton Hampton Virginia 23666
Mary Babb Randolph Cancer Center at West Virginia University Hospitals Morgantown West Virginia 26506
University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison Wisconsin 53792-6164

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00268463, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00268463 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →